ClearPoint Neuro (CLPT) Asset Writedowns and Impairment (2020 - 2026)
ClearPoint Neuro's Asset Writedowns and Impairment history spans 6 years, with the latest figure at -$196000.0 for Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment fell 192.89% to -$196000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $21000.0, a 107.09% increase, with the full-year FY2025 number at $21000.0, up 107.09% from a year prior.
- Asset Writedowns and Impairment hit -$196000.0 in Q4 2025 for ClearPoint Neuro, down from $217000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for CLPT hit a ceiling of $449000.0 in Q3 2023 and a floor of -$361000.0 in Q2 2024.
- Historically, Asset Writedowns and Impairment has averaged $62823.5 across 5 years, with a median of $51000.0 in 2022.
- Biggest five-year swings in Asset Writedowns and Impairment: plummeted 2133.33% in 2022 and later skyrocketed 1520.0% in 2023.
- Tracing CLPT's Asset Writedowns and Impairment over 5 years: stood at $32000.0 in 2021, then crashed by 178.12% to -$25000.0 in 2022, then skyrocketed by 1520.0% to $355000.0 in 2023, then plummeted by 40.56% to $211000.0 in 2024, then plummeted by 192.89% to -$196000.0 in 2025.
- Business Quant data shows Asset Writedowns and Impairment for CLPT at -$196000.0 in Q4 2025, $217000.0 in Q1 2025, and $211000.0 in Q4 2024.